Mangalam Drugs (India) Market Value
| MANGALAM | 90.80 4.36 5.04% |
| Symbol | Mangalam |
Mangalam Drugs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mangalam Drugs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mangalam Drugs.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in Mangalam Drugs on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding Mangalam Drugs And or generate 0.0% return on investment in Mangalam Drugs over 90 days. Mangalam Drugs is related to or competes with Bodal Chemicals, Pritish Nandy, Fineotex Chemical, Mangalore Chemicals, Punjab Chemicals, Paramount Communications, and Uniinfo Telecom. Mangalam Drugs is entity of India. It is traded as Stock on NSE exchange. More
Mangalam Drugs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mangalam Drugs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mangalam Drugs And upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.87 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 10.07 | |||
| Value At Risk | (3.22) | |||
| Potential Upside | 2.52 |
Mangalam Drugs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mangalam Drugs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mangalam Drugs' standard deviation. In reality, there are many statistical measures that can use Mangalam Drugs historical prices to predict the future Mangalam Drugs' volatility.| Risk Adjusted Performance | 0.0706 | |||
| Jensen Alpha | 0.1329 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (1.07) |
Mangalam Drugs And Backtested Returns
At this point, Mangalam Drugs is very steady. Mangalam Drugs And has Sharpe Ratio of 0.0924, which conveys that the firm had a 0.0924 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mangalam Drugs, which you can use to evaluate the volatility of the firm. Please verify Mangalam Drugs' Downside Deviation of 1.87, mean deviation of 1.39, and Risk Adjusted Performance of 0.0706 to check out if the risk estimate we provide is consistent with the expected return of 0.17%. Mangalam Drugs has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.11, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Mangalam Drugs are expected to decrease at a much lower rate. During the bear market, Mangalam Drugs is likely to outperform the market. Mangalam Drugs And right now secures a risk of 1.88%. Please verify Mangalam Drugs And value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to decide if Mangalam Drugs And will be following its current price movements.
Auto-correlation | 0.56 |
Modest predictability
Mangalam Drugs And has modest predictability. Overlapping area represents the amount of predictability between Mangalam Drugs time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mangalam Drugs And price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Mangalam Drugs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 12.47 |
Mangalam Drugs And lagged returns against current returns
Autocorrelation, which is Mangalam Drugs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mangalam Drugs' stock expected returns. We can calculate the autocorrelation of Mangalam Drugs returns to help us make a trade decision. For example, suppose you find that Mangalam Drugs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mangalam Drugs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mangalam Drugs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mangalam Drugs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mangalam Drugs stock over time.
Current vs Lagged Prices |
| Timeline |
Mangalam Drugs Lagged Returns
When evaluating Mangalam Drugs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mangalam Drugs stock have on its future price. Mangalam Drugs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mangalam Drugs autocorrelation shows the relationship between Mangalam Drugs stock current value and its past values and can show if there is a momentum factor associated with investing in Mangalam Drugs And.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.